Medical Devices Pre-Seed Investors & VC Firms
555 firms in this list, with a median first check of $300K. 137 of them lead rounds. Generated from verified public data and updated continuously.
Excellis Holding
TorinoPre-Seed–Series A
2 people
H20 Venture Partners
OxfordPre-Seed–Series A
2 people
Mizuho Capital
TokyoPre-Seed–Late Stage$1.5M – $340M
1 person
Day One Capital
BudapestPre-Seed–Series A$330K – $2.2M
Simpact Ventures
WarsawPre-Seed–Series A$550K – $2M
Sontek Ventures Oy
HelsinkiPre-Seed–Series B
3 people
THENA Capital
Pre-Seed–Series A$6.3M
6 people
CentreStone Ventures
WinnipegPre-Seed–Series A$182.5K – $1.8M
3 people
Serendipity Impact VC
New YorkPre-Seed–Series B
6 people
Global Hands-On VC
TokyoPre-Seed–Growth
2 people
Leksell Social Ventures
StockholmPre-Seed–Series A$1M
2 people
Thynk Capital
Pre-Seed–Series A
1 person
SynBioVen
LondonPre-Seed–Series A
4 people
Cartmell Ventures
AustinPre-Seed–Series A
3 people
Empire State Development – New York Ventures
New YorkPre-Seed–Series B$500K – $1.5M
9 people
GAG Investimentos
BarueriPre-Seed
3 people
iSpring Capital Sdn. Bhd.
Petaling JayaPre-Seed–Series B$150K – $1M
3 people
Matū
AucklandPre-Seed–Growth
Selvedge Venture
LondonPre-Seed–Series A
3 people
Swinburne Elevate Accelerator
HawthornPre-Seed–Series A$10K
Triangle Venture Capital Group
Bensheim-AuerbachPre-Seed–Late Stage$1.6M – $3.2M
3 people
V Ventures
SingaporePre-Seed–Late Stage
6 people
Sahsen Ventures
SeattlePre-Seed–Series A
5 people
BioScience Ventures Group AG
MunichPre-Seed–Series A$220K – $550K
2 people
Related lists
Pre-Seed Investors & VC Firms (5910)Pre-Seed Investors & VC Firms in North America (3177)Pre-Seed Investors & VC Firms in United States (2829)AI & Machine Learning Pre-Seed Investors & VC Firms (1978)SaaS Pre-Seed Investors & VC Firms (1723)Pre-Seed Investors & VC Firms in Europe (1666)Fintech Pre-Seed Investors & VC Firms (1626)Pre-Seed Investors & VC Firms in Global (1563)Healthtech Pre-Seed Investors & VC Firms (1457)Medical Devices Investors & VC Firms (1452)
Data sourced from public filings and firms' own websites — see our methodology.









































